Florida International University
Edit Your Profile
FIU Discovery
Toggle navigation
Browse
Home
People
Organizations
Scholarly & Creative Works
Research Facilities
Support
Edit Your Profile
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Journal
Overview
Research
Identifiers
Other
View All
Overview
publication venue for
A phase 1 and pharmacodynamic study of chronically-dosed, single-agent veliparib (ABT-888) in patients with BRCA1- or BRCA2-mutated cancer or platinum-refractory ovarian or triple-negative breast cancer
. 89:721-735.
2022
A phase i dose-escalation trial of 2-deoxy-d-glucose alone or combined with docetaxel in patients with advanced solid tumors
. 71:523-530.
2013
A multicenter phase II study of docetaxel, oxaliplatin, and bevacizumab in first-line therapy for unresectable locally advanced or metastatic non-squamous cell histology non-small-cell lung cancer (NSCLC)
. 72:1103-1110.
2013
Phase I and pharmacokinetic study of mitomycin C and celecoxib as potential modulators of tumor resistance to irinotecan in patients with solid malignancies
. 63:1073-1082.
2009
A phase I study of gemcitabine plus palliative radiation therapy for advanced lung cancer
. 63:175-179.
2008
Effect of dalteparin and radiation on survival and thromboembolic events in glioblastoma multiforme: a phase II ECOG trial
. 62:227-233.
2008
Thalidomide and celecoxib as potential modulators of irinotecan's activity in cancer patients
. 59:23-33.
2007
Repression of telomerase reverse transcriptase mRNA and hTERT promoter by gambogic acid in human gastric carcinoma cells
. 58:434-443.
2006
Research
category
ONCOLOGY
Category
PHARMACOLOGY & PHARMACY
Category
Identifiers
International Standard Serial Number (ISSN)
0344-5704
Other
journal abbreviation
CANCER CHEMOTH PHARM